<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;ff=20240528141036&amp;utm_medium=rss&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;ff=20240528141036&amp;utm_medium=rss&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 28 May 2024 18:10:39 +0000</lastbuilddate>
<pubDate>Tue, 28 May 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Atherosclerosis in ancient mummified humans: the global HORUS study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38805176/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 28:ehae283. doi: 10.1093/eurheartj/ehae283. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38805176/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38805176</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae283>10.1093/eurheartj/ehae283</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38805176</guid>
<pubDate>Tue, 28 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Randall C Thompson</dc:creator>
<dc:creator>M Linda Sutherland</dc:creator>
<dc:creator>Adel H Allam</dc:creator>
<dc:creator>Alice Paladin</dc:creator>
<dc:creator>Albert R Zink</dc:creator>
<dc:creator>L Samuel Wann</dc:creator>
<dc:creator>James D Sutherland</dc:creator>
<dc:creator>Bruno Frohlich</dc:creator>
<dc:creator>David Hunt</dc:creator>
<dc:creator>Michael I Miyamoto</dc:creator>
<dc:creator>Christopher J Rowan</dc:creator>
<dc:creator>David E Michalik</dc:creator>
<dc:creator>Caleb E Finch</dc:creator>
<dc:creator>Guido P Lombardi</dc:creator>
<dc:creator>Muhammad Al-Tohamy Soliman</dc:creator>
<dc:creator>Janet M Monge</dc:creator>
<dc:creator>Clide M Vallodolid</dc:creator>
<dc:creator>Samantha L Cox</dc:creator>
<dc:creator>Gomaa Abdel-Maksoud</dc:creator>
<dc:creator>Ibrahim Badr</dc:creator>
<dc:creator>Abd El-Halim Nur El-Din</dc:creator>
<dc:creator>Samantha I King</dc:creator>
<dc:creator>Friederike Seyfried</dc:creator>
<dc:creator>Stephanie Panzer</dc:creator>
<dc:creator>Stephanie Zesch</dc:creator>
<dc:creator>Christina Wurst</dc:creator>
<dc:creator>Marco Samadelli</dc:creator>
<dc:creator>Giulia Gregori</dc:creator>
<dc:creator>Marco Rossani</dc:creator>
<dc:creator>Guido Valverde</dc:creator>
<dc:creator>Frank Maixner</dc:creator>
<dc:creator>Federica Facchetti</dc:creator>
<dc:creator>Scott Warnasch</dc:creator>
<dc:creator>Lucia Watson</dc:creator>
<dc:creator>Jagat Narula</dc:creator>
<dc:creator>Andrew J Nelson</dc:creator>
<dc:creator>Gregrory S Thomas</dc:creator>
<dc:date>2024-05-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Atherosclerosis in ancient mummified humans: the global HORUS study</dc:title>
<dc:identifier>pmid:38805176</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae283</dc:identifier>
</item>
<item>
<title>Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38804269/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 28:ehae247. doi: 10.1093/eurheartj/ehae247. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38804269/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38804269</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae247>10.1093/eurheartj/ehae247</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38804269</guid>
<pubDate>Tue, 28 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Diana A Gorog</dc:creator>
<dc:date>2024-05-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters</dc:title>
<dc:identifier>pmid:38804269</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae247</dc:identifier>
</item>
<item>
<title>Genetic predictors of traits in elderly subjects: risk of survival bias and reverse causation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38804264/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 28:ehae295. doi: 10.1093/eurheartj/ehae295. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38804264/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38804264</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae295>10.1093/eurheartj/ehae295</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38804264</guid>
<pubDate>Tue, 28 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Stephen Burgess</dc:creator>
<dc:creator>Ang Zhou</dc:creator>
<dc:date>2024-05-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Genetic predictors of traits in elderly subjects: risk of survival bias and reverse causation</dc:title>
<dc:identifier>pmid:38804264</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae295</dc:identifier>
</item>
<item>
<title>Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38804262/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In PCI patients, PFCS and platelet reactivity demonstrated important relationships in predicting clinical prognosis. Their combined assessment may enhance post-PCI risk stratification for personalized antithrombotic therapy.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 28:ehae296. doi: 10.1093/eurheartj/ehae296. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Platelet-fibrin clot strength (PFCS) is linked to major adverse cardiovascular event (MACE) risk. However, the association between PFCS and platelet reactivity and their prognostic implication remains uncertain in patients undergoing percutaneous coronary intervention (PCI).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In PCI-treated patients (n = 2512) from registry data from January 2010 to November 2018 in South Korea, PFCS using thromboelastography and platelet reactivity using VerifyNow were measured. High PFCS (PFCSHigh) was defined as thromboelastography maximal amplitude ≥ 68 mm, and high platelet reactivity (HPR) was defined as >;208 P2Y12 reaction units. Patients were stratified into four groups according to maximal amplitude and P2Y12 reaction unit levels: (i) normal platelet reactivity (NPR)-PFCSNormal (31.8%), (ii) HPR-PFCSNormal (29.0%), (iii) NPR-PFCSHigh (18.1%), and (iv) HPR-PFCSHigh (21.1%). Major adverse cardiovascular event (all-cause death, myocardial infarction, or stroke) and major bleeding were followed up to 4 years.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: High platelet reactivity and PFCSHigh showed an additive effect for clinical outcomes (log-rank test, P &lt; .001). Individuals with NPR-PFCSNormal, NPR-PFCSHigh, HPR-PFCSNormal, and HPR-PFCSHigh demonstrated MACE incidences of 7.5%, 12.6%, 13.4%, and 19.3%, respectively. The HPR-PFCSHigh group showed significantly higher risks of MACE compared with the NPR-PFCSNormal group [adjusted hazard ratio (HRadj) 1.89; 95% confidence interval (CI) 1.23-2.91; P = .004] and the HPR-PFCSNormal group (HRadj 1.60; 95% CI 1.12-2.27; P = .009). Similar results were observed for all-cause death. Compared with HPR-PFCSNormal phenotype, NPR-PFCSNormal phenotype was associated with a higher risk of major bleeding (HRadj 3.12; 95% CI 1.30-7.69; P = .010).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In PCI patients, PFCS and platelet reactivity demonstrated important relationships in predicting clinical prognosis. Their combined assessment may enhance post-PCI risk stratification for personalized antithrombotic therapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38804262/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38804262</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae296>10.1093/eurheartj/ehae296</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38804262</guid>
<pubDate>Tue, 28 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Osung Kwon</dc:creator>
<dc:creator>Jong-Hwa Ahn</dc:creator>
<dc:creator>Jin-Sin Koh</dc:creator>
<dc:creator>Yongwhi Park</dc:creator>
<dc:creator>Seok Jae Hwang</dc:creator>
<dc:creator>Udaya S Tantry</dc:creator>
<dc:creator>Paul A Gurbel</dc:creator>
<dc:creator>Jin-Yong Hwang</dc:creator>
<dc:creator>Young-Hoon Jeong</dc:creator>
<dc:date>2024-05-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions</dc:title>
<dc:identifier>pmid:38804262</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae296</dc:identifier>
</item>
<item>
<title>Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38804148/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Among patients with bicuspid aortic valve without severe valvular dysfunction, atorvastatin treatment was not effective in reducing the progression of ascending aorta dilation and aortic valve calcification during 3 years of treatment despite a significant reduction in low-density lipoprotein cholesterol levels.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.123.067537. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Ascending aorta dilation and aortic valve degeneration are common complications in patients with bicuspid aortic valve. Several retrospective studies have suggested the benefit of statins in reducing these complications. This study aimed to determine whether atorvastatin treatment is effective in reducing the growth of aortic diameters in bicuspid aortic valve and if it slows the progression of valve calcification.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In a randomized clinical trial, 220 patients with bicuspid aortic valve (43 women; 46±13 years of age) were included and treated with either 20 mg of atorvastatin per day or placebo for 3 years. Inclusion criteria were ≥18 years of age, nonsevere valvular dysfunction, nonsevere valve calcification, and ascending aorta diameter ≤50 mm. Computed tomography and echocardiography studies were performed at baseline and after 3 years of treatment.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: During follow-up, 28 patients (12.7%) discontinued medical treatment (15 on atorvastatin and 13 taking placebo). Thus, 192 patients completed the 36 months of treatment. Low-density lipoprotein cholesterol levels decreased significantly in the atorvastatin group (median [interquartile range], -30 mg/dL [-51.65 to -1.75 mg/dL] versus 6 mg/dL [-4, 22.5 mg/dL]; <i>P</i>&lt;0.001). The maximum ascending aorta diameter increased with no differences between groups: 0.65 mm (95% CI, 0.45-0.85) in the atorvastatin group and 0.74 mm (95% CI, 0.45-1.04) in the placebo group (<i>P</i>=0.613). Similarly, no significant differences were found for the progression of the aortic valve calcium score (<i>P</i>=0.167) or valvular dysfunction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Among patients with bicuspid aortic valve without severe valvular dysfunction, atorvastatin treatment was not effective in reducing the progression of ascending aorta dilation and aortic valve calcification during 3 years of treatment despite a significant reduction in low-density lipoprotein cholesterol levels.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrialsregister.eu; Unique identifier: 2015-001808-57; URL: https://www.clinicaltrials.gov; Unique identifier: NCT02679261.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38804148/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38804148</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067537>10.1161/CIRCULATIONAHA.123.067537</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38804148</guid>
<pubDate>Tue, 28 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Arturo Evangelista</dc:creator>
<dc:creator>Laura Galian-Gay</dc:creator>
<dc:creator>Andrea Guala</dc:creator>
<dc:creator>Gisela Teixido-Tura</dc:creator>
<dc:creator>Francisco Calvo-Iglesias</dc:creator>
<dc:creator>Teresa Sevilla</dc:creator>
<dc:creator>Javier Bermejo</dc:creator>
<dc:creator>Irene Méndez</dc:creator>
<dc:creator>Violeta Sánchez</dc:creator>
<dc:creator>Juan M Robredo Carmona</dc:creator>
<dc:creator>Josep M Alegret</dc:creator>
<dc:creator>Elena Ferrer</dc:creator>
<dc:creator>Daniel Saura</dc:creator>
<dc:creator>Aroa Ruiz-Muñoz</dc:creator>
<dc:creator>Lydia Dux-Santoy</dc:creator>
<dc:creator>María Ángeles Carmona</dc:creator>
<dc:creator>Marina Huguet</dc:creator>
<dc:creator>Hug Cuellar-Calabria</dc:creator>
<dc:creator>Augusto Sao-Avilés</dc:creator>
<dc:creator>Ignacio Ferreira-González</dc:creator>
<dc:creator>Jose F Rodríguez-Palomares</dc:creator>
<dc:date>2024-05-28</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial</dc:title>
<dc:identifier>pmid:38804148</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067537</dc:identifier>
</item>
<item>
<title>Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38804138/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This study demonstrates a systemic pathogenic impact of skeletal muscle SIRT3 deficiency in remote pulmonary vascular remodeling and PH-HFpEF. This study suggests a new endocrine signaling axis that links skeletal muscle health and SIRT3 deficiency to remote CNPY2 regulation in the pulmonary vasculature through myokine LOXL2. Our data also identify skeletal muscle SIRT3, myokine LOXL2, and CNPY2 as potential targets for the treatment of PH-HFpEF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Pulmonary hypertension (PH) is a major complication linked to adverse outcomes in heart failure with preserved ejection fraction (HFpEF), yet no specific therapies exist for PH associated with HFpEF (PH-HFpEF). We have recently reported on the role of skeletal muscle SIRT3 (sirtuin-3) in modulation of PH-HFpEF, suggesting a novel endocrine signaling pathway for skeletal muscle modulation of pulmonary vascular remodeling. In this study, we attempted to define the processes by which skeletal muscle SIRT3 defects affect pulmonary vascular health in PH-HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: Skeletal muscle-specific <i>Sirt3</i> knockout mice (<i>Sirt3</i><sup>skm-/-</sup>) exhibited reduced pulmonary vascular density accompanied by pulmonary vascular proliferative remodeling and elevated pulmonary pressures. Using mass spectrometry-based comparative secretome analysis, we demonstrated elevated secretion of LOXL2 (lysyl oxidase homolog 2) in SIRT3-deficient skeletal muscle cells. Elevated circulation and protein expression levels of LOXL2 were also observed in plasma and skeletal muscle of <i>Sirt3</i><sup>skm-/-</sup> mice, a rat model of PH-HFpEF, and humans with PH-HFpEF. In addition, expression levels of CNPY2 (canopy fibroblast growth factor signaling regulator 2), a known proliferative and angiogenic factor, were increased in pulmonary artery endothelial cells and pulmonary artery smooth muscle cells of <i>Sirt3</i><sup>skm-/-</sup> mice and animal models of PH-HFpEF. CNPY2 levels were also higher in pulmonary artery smooth muscle cells of subjects with obesity compared with nonobese subjects. Moreover, treatment with recombinant LOXL2 protein promoted pulmonary artery endothelial cell migration/proliferation and pulmonary artery smooth muscle cell proliferation through regulation of CNPY2-p53 signaling. Last, skeletal muscle-specific <i>Loxl2</i> deletion decreased pulmonary artery endothelial cell and pulmonary artery smooth muscle cell expression of CNPY2 and improved pulmonary pressures in mice with high-fat diet-induced PH-HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study demonstrates a systemic pathogenic impact of skeletal muscle SIRT3 deficiency in remote pulmonary vascular remodeling and PH-HFpEF. This study suggests a new endocrine signaling axis that links skeletal muscle health and SIRT3 deficiency to remote CNPY2 regulation in the pulmonary vasculature through myokine LOXL2. Our data also identify skeletal muscle SIRT3, myokine LOXL2, and CNPY2 as potential targets for the treatment of PH-HFpEF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38804138/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38804138</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068624>10.1161/CIRCULATIONAHA.124.068624</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38804138</guid>
<pubDate>Tue, 28 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Jia-Rong Jheng</dc:creator>
<dc:creator>Yang Bai</dc:creator>
<dc:creator>Kentaro Noda</dc:creator>
<dc:creator>Joshua R Huot</dc:creator>
<dc:creator>Todd Cook</dc:creator>
<dc:creator>Amanda Fisher</dc:creator>
<dc:creator>Yi-Yun Chen</dc:creator>
<dc:creator>Dmitry A Goncharov</dc:creator>
<dc:creator>Elena A Goncharova</dc:creator>
<dc:creator>Marc A Simon</dc:creator>
<dc:creator>Yingze Zhang</dc:creator>
<dc:creator>Daniel E Forman</dc:creator>
<dc:creator>Mauricio Rojas</dc:creator>
<dc:creator>Roberto F Machado</dc:creator>
<dc:creator>Johan Auwerx</dc:creator>
<dc:creator>Mark T Gladwin</dc:creator>
<dc:creator>Yen-Chun Lai</dc:creator>
<dc:date>2024-05-28</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction</dc:title>
<dc:identifier>pmid:38804138</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068624</dc:identifier>
</item>
<item>
<title>The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38801737/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 27;45(20):1769-1773. doi: 10.1093/eurheartj/ehae293.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38801737/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38801737</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae293>10.1093/eurheartj/ehae293</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38801737</guid>
<pubDate>Mon, 27 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-05-27</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease</dc:title>
<dc:identifier>pmid:38801737</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae293</dc:identifier>
</item>
<item>
<title>Correction to: Severe aortic stenosis: secular trends of incidence and outcomes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38801656/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 27:ehae144. doi: 10.1093/eurheartj/ehae144. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38801656/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38801656</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae144>10.1093/eurheartj/ehae144</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38801656</guid>
<pubDate>Mon, 27 May 2024 06:00:00 -0400</pubDate>
<dc:date>2024-05-27</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction to: Severe aortic stenosis: secular trends of incidence and outcomes</dc:title>
<dc:identifier>pmid:38801656</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae144</dc:identifier>
</item>
<item>
<title>Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38795705/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Recent studies suggest that human-associated bacteria interact with host-produced steroids, but the mechanisms and physiological impact of such interactions remain unclear. Here, we show that the human gut bacteria Gordonibacter pamelaeae and Eggerthella lenta convert abundant biliary corticoids into progestins through 21-dehydroxylation, thereby transforming a class of immuno- and metabo-regulatory steroids into a class of sex hormones and neurosteroids. Using comparative genomics, homologous...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 21:S0092-8674(24)00514-2. doi: 10.1016/j.cell.2024.05.005. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Recent studies suggest that human-associated bacteria interact with host-produced steroids, but the mechanisms and physiological impact of such interactions remain unclear. Here, we show that the human gut bacteria Gordonibacter pamelaeae and Eggerthella lenta convert abundant biliary corticoids into progestins through 21-dehydroxylation, thereby transforming a class of immuno- and metabo-regulatory steroids into a class of sex hormones and neurosteroids. Using comparative genomics, homologous expression, and heterologous expression, we identify a bacterial gene cluster that performs 21-dehydroxylation. We also uncover an unexpected role for hydrogen gas production by gut commensals in promoting 21-dehydroxylation, suggesting that hydrogen modulates secondary metabolism in the gut. Levels of certain bacterial progestins, including allopregnanolone, better known as brexanolone, an FDA-approved drug for postpartum depression, are substantially increased in feces from pregnant humans. Thus, bacterial conversion of corticoids into progestins may affect host physiology, particularly in the context of pregnancy and women's health.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38795705/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38795705</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.005>10.1016/j.cell.2024.05.005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38795705</guid>
<pubDate>Sat, 25 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Megan D McCurry</dc:creator>
<dc:creator>Gabriel D D'Agostino</dc:creator>
<dc:creator>Jasmine T Walsh</dc:creator>
<dc:creator>Jordan E Bisanz</dc:creator>
<dc:creator>Ines Zalosnik</dc:creator>
<dc:creator>Xueyang Dong</dc:creator>
<dc:creator>David J Morris</dc:creator>
<dc:creator>Joshua R Korzenik</dc:creator>
<dc:creator>Andrea G Edlow</dc:creator>
<dc:creator>Emily P Balskus</dc:creator>
<dc:creator>Peter J Turnbaugh</dc:creator>
<dc:creator>Jun R Huh</dc:creator>
<dc:creator>A Sloan Devlin</dc:creator>
<dc:date>2024-05-25</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas</dc:title>
<dc:identifier>pmid:38795705</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.005</dc:identifier>
</item>
<item>
<title>SnapShot: Cell size control</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788693/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Cell size exhibits remarkable diversity across and within organisms. Size variation correlates with DNA content and growth rates and is regulated by complex models of cell size control that are yet to be mechanistically defined. To view this SnapShot, open or download the PDF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2896-2896.e1. doi: 10.1016/j.cell.2024.04.030.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cell size exhibits remarkable diversity across and within organisms. Size variation correlates with DNA content and growth rates and is regulated by complex models of cell size control that are yet to be mechanistically defined. To view this SnapShot, open or download the PDF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788693/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788693</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.030>10.1016/j.cell.2024.04.030</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788693</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Bruce Futcher</dc:creator>
<dc:creator>Douglas R Kellogg</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>SnapShot: Cell size control</dc:title>
<dc:identifier>pmid:38788693</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.030</dc:identifier>
</item>
<item>
<title>SnapShot: Condensates in plant biology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788692/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Plant cells share a number of biological condensates with cells from other eukaryotes. There are, however, a growing number of plant-specific condensates that support different cellular functions. Condensates operating in different plant tissues contribute to aspects of development and stress responses. To view this SnapShot, open or download the PDF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2894-2894.e1. doi: 10.1016/j.cell.2024.04.011.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Plant cells share a number of biological condensates with cells from other eukaryotes. There are, however, a growing number of plant-specific condensates that support different cellular functions. Condensates operating in different plant tissues contribute to aspects of development and stress responses. To view this SnapShot, open or download the PDF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788692/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788692</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.011>10.1016/j.cell.2024.04.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788692</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Xiaofeng Fang</dc:creator>
<dc:creator>Pilong Li</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>SnapShot: Condensates in plant biology</dc:title>
<dc:identifier>pmid:38788692</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.011</dc:identifier>
</item>
<item>
<title>A microbial-derived succinylated bile acid to safeguard liver health</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788691/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>In this issue of Cell, Nie and co-authors report that the microbe-derived bile acid (BA) 3-succinylated cholic acid protects against the progression of metabolic dysfunction-associated liver disease. Intriguingly, its protective mechanism does not involve traditional BA signaling pathways but is instead linked to the proliferation of the commensal microbe Akkermansia muciniphila.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2687-2689. doi: 10.1016/j.cell.2024.04.020.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In this issue of Cell, Nie and co-authors report that the microbe-derived bile acid (BA) 3-succinylated cholic acid protects against the progression of metabolic dysfunction-associated liver disease. Intriguingly, its protective mechanism does not involve traditional BA signaling pathways but is instead linked to the proliferation of the commensal microbe Akkermansia muciniphila.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788691/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788691</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.020>10.1016/j.cell.2024.04.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788691</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Alessia Perino</dc:creator>
<dc:creator>Hadrien Demagny</dc:creator>
<dc:creator>Kristina Schoonjans</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A microbial-derived succinylated bile acid to safeguard liver health</dc:title>
<dc:identifier>pmid:38788691</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.020</dc:identifier>
</item>
<item>
<title>The SkillsCenter: Creating scalable research opportunities for STEM students</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788690/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Undergraduate students generally need laboratory skills and experience to be accepted into a position within an academic lab or a company. However, those settings are traditionally where students would develop that necessary expertise. We developed a laboratory course paradigm to equip students with the skills they need to access future opportunities.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2682-2686. doi: 10.1016/j.cell.2024.04.017.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Undergraduate students generally need laboratory skills and experience to be accepted into a position within an academic lab or a company. However, those settings are traditionally where students would develop that necessary expertise. We developed a laboratory course paradigm to equip students with the skills they need to access future opportunities.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788690/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788690</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.017>10.1016/j.cell.2024.04.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788690</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Zachary Hazlett</dc:creator>
<dc:creator>Beiyi Xu</dc:creator>
<dc:creator>Jennifer K Knight</dc:creator>
<dc:creator>Michael W Klymkowsky</dc:creator>
<dc:creator>Michael H B Stowell</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The SkillsCenter: Creating scalable research opportunities for STEM students</dc:title>
<dc:identifier>pmid:38788690</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.017</dc:identifier>
</item>
<item>
<title>The purpose and ubiquity of turnover</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788689/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Turnover-constant component production and destruction-is ubiquitous in biology. Turnover occurs across organisms and scales, including for RNAs, proteins, membranes, macromolecular structures, organelles, cells, hair, feathers, nails, antlers, and teeth. For many systems, turnover might seem wasteful when degraded components are often fully functional. Some components turn over with shockingly high rates and others do not turn over at all, further making this process enigmatic. However,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2657-2681. doi: 10.1016/j.cell.2024.04.034.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Turnover-constant component production and destruction-is ubiquitous in biology. Turnover occurs across organisms and scales, including for RNAs, proteins, membranes, macromolecular structures, organelles, cells, hair, feathers, nails, antlers, and teeth. For many systems, turnover might seem wasteful when degraded components are often fully functional. Some components turn over with shockingly high rates and others do not turn over at all, further making this process enigmatic. However, turnover can address fundamental problems by yielding powerful properties, including regeneration, rapid repair onset, clearance of unpredictable damage and errors, maintenance of low constitutive levels of disrepair, prevention of stable hazards, and transitions. I argue that trade-offs between turnover benefits and metabolic costs, combined with constraints on turnover, determine its presence and rates across distinct contexts. I suggest that the limits of turnover help explain aging and that turnover properties and the basis for its levels underlie this fundamental component of life.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788689/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788689</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.034>10.1016/j.cell.2024.04.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788689</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Peter W Reddien</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The purpose and ubiquity of turnover</dc:title>
<dc:identifier>pmid:38788689</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.034</dc:identifier>
</item>
<item>
<title>Mechanobiology: Shaping the future of cellular form and function</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788688/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Mechanobiology-the field studying how cells produce, sense, and respond to mechanical forces-is pivotal in the analysis of how cells and tissues take shape in development and disease. As we venture into the future of this field, pioneers share their insights, shaping the trajectory of future research and applications.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2652-2656. doi: 10.1016/j.cell.2024.04.006.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Mechanobiology-the field studying how cells produce, sense, and respond to mechanical forces-is pivotal in the analysis of how cells and tissues take shape in development and disease. As we venture into the future of this field, pioneers share their insights, shaping the trajectory of future research and applications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788688/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788688</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.006>10.1016/j.cell.2024.04.006</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788688</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Celeste M Nelson</dc:creator>
<dc:creator>Bailong Xiao</dc:creator>
<dc:creator>Sara A Wickström</dc:creator>
<dc:creator>Yves F Dufrêne</dc:creator>
<dc:creator>Daniel J Cosgrove</dc:creator>
<dc:creator>Carl-Philipp Heisenberg</dc:creator>
<dc:creator>Sirio Dupont</dc:creator>
<dc:creator>Amy E Shyer</dc:creator>
<dc:creator>Alan R Rodrigues</dc:creator>
<dc:creator>Xavier Trepat</dc:creator>
<dc:creator>Alba Diz-Muñoz</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Mechanobiology: Shaping the future of cellular form and function</dc:title>
<dc:identifier>pmid:38788688</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.006</dc:identifier>
</item>
<item>
<title>Establishing a conceptual framework for holistic cell states and state transitions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788687/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Cell states were traditionally defined by how they looked, where they were located, and what functions they performed. In this post-genomic era, the field is largely focused on a molecular view of cell state. Moving forward, we anticipate that the observables used to define cell states will evolve again as single-cell imaging and analytics are advancing at a breakneck pace via the collection of large-scale, systematic cell image datasets and the application of quantitative image-based data...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2633-2651. doi: 10.1016/j.cell.2024.04.035.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cell states were traditionally defined by how they looked, where they were located, and what functions they performed. In this post-genomic era, the field is largely focused on a molecular view of cell state. Moving forward, we anticipate that the observables used to define cell states will evolve again as single-cell imaging and analytics are advancing at a breakneck pace via the collection of large-scale, systematic cell image datasets and the application of quantitative image-based data science methods. This is, therefore, a key moment in the arc of cell biological research to develop approaches that integrate the spatiotemporal observables of the physical structure and organization of the cell with molecular observables toward the concept of a holistic cell state. In this perspective, we propose a conceptual framework for holistic cell states and state transitions that is data-driven, practical, and useful to enable integrative analyses and modeling across many data types.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788687/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788687</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.035>10.1016/j.cell.2024.04.035</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788687</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Susanne M Rafelski</dc:creator>
<dc:creator>Julie A Theriot</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Establishing a conceptual framework for holistic cell states and state transitions</dc:title>
<dc:identifier>pmid:38788687</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.035</dc:identifier>
</item>
<item>
<title>What comes next in glycobiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788686/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Glycans, with their variable compositions and highly dynamic conformations, vastly expand the heterogeneity of whatever factor or cell they are attached to. These properties make them crucial contributors to biological function and organismal health and also very difficult to study. That may be changing as we look to the future of glycobiology.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2628-2632. doi: 10.1016/j.cell.2024.04.028.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Glycans, with their variable compositions and highly dynamic conformations, vastly expand the heterogeneity of whatever factor or cell they are attached to. These properties make them crucial contributors to biological function and organismal health and also very difficult to study. That may be changing as we look to the future of glycobiology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788686/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788686</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.028>10.1016/j.cell.2024.04.028</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788686</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Peter H Seeberger</dc:creator>
<dc:creator>Yun Ge</dc:creator>
<dc:creator>Christine M Szymanski</dc:creator>
<dc:creator>Daniel Kolarich</dc:creator>
<dc:creator>Morten Thaysen-Andersen</dc:creator>
<dc:creator>Nicolle H Packer</dc:creator>
<dc:creator>Elisa Fadda</dc:creator>
<dc:creator>Benjamin Davis</dc:creator>
<dc:creator>Shoko Nishihara</dc:creator>
<dc:creator>Gabriel A Rabinovich</dc:creator>
<dc:creator>Peter D Kwong</dc:creator>
<dc:creator>Richard Strasser</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>What comes next in glycobiology</dc:title>
<dc:identifier>pmid:38788686</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.028</dc:identifier>
</item>
<item>
<title>Mitochondria at the crossroads of health and disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788685/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>Mitochondria reside at the crossroads of catabolic and anabolic metabolism-the essence of life. How their structure and function are dynamically tuned in response to tissue-specific needs for energy, growth repair, and renewal is being increasingly understood. Mitochondria respond to intrinsic and extrinsic stresses and can alter cell and organismal function by inducing metabolic signaling within cells and to distal cells and tissues. Here, we review how the centrality of mitochondrial functions...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2601-2627. doi: 10.1016/j.cell.2024.04.037.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Mitochondria reside at the crossroads of catabolic and anabolic metabolism-the essence of life. How their structure and function are dynamically tuned in response to tissue-specific needs for energy, growth repair, and renewal is being increasingly understood. Mitochondria respond to intrinsic and extrinsic stresses and can alter cell and organismal function by inducing metabolic signaling within cells and to distal cells and tissues. Here, we review how the centrality of mitochondrial functions manifests in health and a broad spectrum of diseases and aging.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788685/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788685</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.037>10.1016/j.cell.2024.04.037</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788685</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Anu Suomalainen</dc:creator>
<dc:creator>Jodi Nunnari</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Mitochondria at the crossroads of health and disease</dc:title>
<dc:identifier>pmid:38788685</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.037</dc:identifier>
</item>
<item>
<title>Toward new horizons in cell biology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788684/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>This 50th Anniversary Focus on Cell Biology looks at where the field is going. What big principles are emerging? What's making cell biology research thrive? We're celebrating by showcasing how this classic field is forging ahead.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 May 23;187(11):2599-2600. doi: 10.1016/j.cell.2024.04.036.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This 50th Anniversary Focus on Cell Biology looks at where the field is going. What big principles are emerging? What's making cell biology research thrive? We're celebrating by showcasing how this classic field is forging ahead.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788684/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788684</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.036>10.1016/j.cell.2024.04.036</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788684</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Cell Editorial Team</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Toward new horizons in cell biology</dc:title>
<dc:identifier>pmid:38788684</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.036</dc:identifier>
</item>
<item>
<title>Taking the sex out of atrial fibrillation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38788131/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 27;45(20):1828-1830. doi: 10.1093/eurheartj/ehae256.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38788131/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38788131</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae256>10.1093/eurheartj/ehae256</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38788131</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>David Brieger</dc:creator>
<dc:creator>Ben Freedman</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Taking the sex out of atrial fibrillation</dc:title>
<dc:identifier>pmid:38788131</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae256</dc:identifier>
</item>
<item>
<title>A hidden cause of middle-aged onset heart failure with preserved ejection fraction: a GTPBP3 variant</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38785384/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240528141036&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 May 24:ehae309. doi: 10.1093/eurheartj/ehae309. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38785384/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240528141036&v=2.18.0.post9+e462414">38785384</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae309>10.1093/eurheartj/ehae309</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38785384</guid>
<pubDate>Fri, 24 May 2024 06:00:00 -0400</pubDate>
<dc:creator>Toshiyuki Yano</dc:creator>
<dc:creator>Atsuhito Takeda</dc:creator>
<dc:creator>Kei Murayama</dc:creator>
<dc:date>2024-05-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A hidden cause of middle-aged onset heart failure with preserved ejection fraction: a GTPBP3 variant</dc:title>
<dc:identifier>pmid:38785384</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae309</dc:identifier>
</item>





























</channel>
</rss>